Buprenorphine Transdermal Patches (BTDS) in Subjects With Osteoarthritis Pain. Includes a 52-week Extension Phase.
Clinical trial NCT00320801 · TERMINATED
Trial details
- NCT number
- NCT00320801
- Sponsor
- Purdue Pharma LP
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-01-01
- Primary completion
- 2005-03-01
- Enrollment
- 188
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.